Business · 09/11/2017Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Blood Products Advisory Committee
Summary
The Food and Drug Administration (FDA) is hosting a public meeting of the Blood Products Advisory Committee to provide advice on blood and blood-derived products. The meeting is open to the public and will be held to discuss regulatory issues related to these products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →